Novel formulations of tumour-associated peptides binding to...

Details Novel formulations of tumour-associated peptides binding to... Novel formulations of tumour-associated peptides binding to...

A - Human Necessities

61

K

A61K 39/00 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2665510

The present invention relates to novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal and brain cancer, in particular glioma, especially glioblastoma cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumour immune responses.

Affiliated with

Also associated with

Rating

Novel formulations of tumour-associated peptides binding to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel formulations of tumour-associated peptides binding to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel formulations of tumour-associated peptides binding to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2084333